Articles

Cracking RAS: It took over 30 years to hit this ubiquitous oncogene – was it worth the wait?

RAS oncogenes and their proteins have central roles in almost all cancers, including leukaemias, multiple myelomas, skin cancers and many solid tumours, making the RAS protein family an ideal cancer target. But…